TF and cancer: A consensus statement also indicated that IV iron substitution is reasonable in patients with anemia of chronic disease including cancer or chronic inflammatory diseases such as cardiac heart failure, inflammatory bowel syndrome or chronic kidney disease, if ferritin is below 300ng/ml and the transferrin saturation is below 20% [30].